🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This multicenter retrospective study evaluated consecutive patients with la...
Status
Completed
Location
The Second Affiliated Hospital of Guangzhou Medical University
Start Date
2019-07-01
Trial ID
NCT06265883
Treatments Being Tested
This research study is studying Lenvatinib in combination with Pembrolizuma...
Status
Recruiting
Location
Yale University
Start Date
2025-07-18
Trial ID
NCT04645602
Treatments Being Tested
The investigators propose to initiate a study assessing the efficacy and sa...
Status
Unknown
Location
Peking Union Medical College Hospital
Start Date
2023-02-01
Trial ID
NCT06241105
Treatments Being Tested
This study intends to evaluate the efficacy and safety of drug-eluting tran...
Status
Recruiting
Location
Chinese PLA General hospital
Start Date
2024-10-01
Trial ID
NCT06609863
Treatments Being Tested
This study will evaluate the safety and efficacy of durvalumab in combinati...
Status
Unknown
Location
Multiple Locations
Start Date
2020-08-31
Trial ID
NCT04444193
Treatments Being Tested
This is a two center, open label, non-randomized Phase II study of lenvatin...
Status
Withdrawn
Location
University of California, San Diego
Start Date
2018-07-01
Trial ID
NCT02846766
Treatments Being Tested
This study will look at whether adding daily oral zinc supplements to targe...
Status
Not Yet Recruiting
Location
The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital)
Start Date
2026-09-01
Trial ID
NCT07793695
What is this study about? This is a medical research study testing a new dr...
Status
Recruiting
Location
Shanghai Sixth Peolple'S Hospital
Start Date
2025-12-25
Trial ID
NCT07359053
The goal of this study is to evaluate the efficacy and safety of pembrolizu...
Status
Active Not Recruiting
Location
The University of Alabama at Birmingham ( Site 0010)
Start Date
2021-04-14
Trial ID
NCT04736706
Treatments Being Tested
Purpose: This phase II clinical trial evaluates whether a combination of li...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-06-30
Trial ID
NCT07685535
Treatments Being Tested